TrialThoracic cancer2022

Apatinib as maintenance therapy following standard first-line chemotherapy in extensive disease small cell lung cancer: A phase II single-arm trial.

Fei Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.